IS 16112:2013
Dear Reader, The Government of India has issued an important amendment under the Bureau of Indian Standards Act, 2016 — the Beta Picoline (Quality Control) Amendment Order, 2024. This update is applicable to all existing BIS licence holders, new applicants, manufacturers, importers, and product sellers dealing with Beta Picoline.
This Quality Control Order mandates that all goods or articles of Beta Picoline must strictly conform to the Indian Standard IS 16112:2013.
Every product covered under this order must bear the Standard Mark (ISI Mark), granted under a valid BIS licence in accordance with Scheme–I of Schedule–II of the Bureau of Indian Standards (Conformity Assessment) Regulations, 2018.
It is important to note that the provisions of this order do not apply to goods or articles intended exclusively for export, provided they meet the specifications required by the foreign purchaser.
The Bureau of Indian Standards (BIS) has been designated as the certifying and enforcing authority for ensuring compliance with this order.
Any manufacturer, importer, or seller found in violation of this Quality Control Order will face penalties under the BIS Act, 2016.
Applicable Standard: IS 16112:2013
Implementation Authority: Bureau of Indian Standards (Govt. of India)
Implementation Date: 13th March 2026
Exemption: Products manufactured solely for export
Bureau of Indian Standards Manak Bhawan 9, B.S. Zafar Marg, New Delhi - 110002
Tel: +91-11-23231903
Email : chemicals@bis.gov.in
Implementation Dates : 13th March 2026
At every stage of compliance, the knowledgeable consultants at EVTL INDIA are prepared to help, offering you the best services available in India. Obtain comprehensive details regarding the certification required for your product to join the Indian market and develop a strong customer base.
The contents provided in this update are solely meant for general informational purposes. Before you make decisions or take action based on the information provided, it is advised to seek professional legal consultation.